Ezutromid, also known as BMN-195 and SMTC-1100, is a first orally bioavailable utrophin's translation modulator. Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle.
仅供研究使用。 我们不向患者出售。
| 名称 | Ezutromid |
|---|---|
| Iupac 化学名称 | Ezutromid |
| 同义词 | BMN-195; BMN 195; BMN195; SMTC-1100; SMTC1100; SMTC 1100; VOX-C1100 |
| 英文同义词 | BMN-195; BMN 195; BMN195; SMTC-1100; SMTC1100; SMTC 1100; VOX-C1100 |
| 分子式 | C19H15NO3S |
| 分子量 | 337.39 |
| InChiKey | |
| InChi | |
| Cas号 | 945531-77-1 |
| 相关CAS号 |
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |